GlassScriptPhysician profile
Matthew K Lawlor
NPI 1508247727
$22,440.96
in general payments reported to CMS, 2019-2025
18 companies · $313 in 2025
The $313 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $342 · 2020: $463 · 2021: $175 · 2022: $2,422 · 2023: $17K · 2024: $2,199 · 2025: $313.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $15K · Food and Beverage: $2,568 · Travel and Lodging: $1,471.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $15,000.00 |
| Food and Beverage | $2,567.68 |
| Travel and Lodging | $1,471.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $15,487.67 | 2022-2024 | Avvigo Guidance System, Watchman Flx, Watchman Access System |
| Abbott Laboratories | $2,218.38 | 2020-2025 | Mitraclip, Navitor, Portico |
| Medtronic, INC. | $1,344.54 | 2022-2025 | Corevalve Evolut R, Onyx Frontier, Launcher |
| Osprey Medical INC | $1,250.00 | 2022 | |
| Edwards Lifesciences Corporation | $519.44 | 2021-2024 | Sapien 3 Ultra Resilia |
| Abiomed | $335.37 | 2022-2024 | Impella |
| Ancora Heart, INC. | $317.00 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $217.73 | 2019-2021 | |
| Chiesi USA, INC. | $192.57 | 2020-2023 | Kengreal |
| Astrazeneca Pharmaceuticals LP | $129.40 | 2019 | |
| Heartflow, INC. | $128.29 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $92.13 | 2022-2024 | Jardiance |
| Novartis Pharmaceuticals Corporation | $64.18 | 2021-2022 | |
| Asahi Intecc USA, INC. | $53.10 | 2024 | Peripheral Vascular |
| Acist Medical Systems, INC. | $27.76 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $25.86 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $22.35 | 2022 | |
| Janssen Pharmaceuticals, INC | $15.19 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Lawlor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.